Role of myelin-associated inhibitors in axonal repair after spinal cord injury

Experimental Neurology

Volumn 235, Issue 1, 2012, Pages 33-42

  Lee, Jae K ^a,b   Zheng, Binhai ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

Axon regeneration; MAG; Myelin; NgR1; Nogo; Nogo receptor; OMgp; Spinal cord injury; Sprouting

Indexed keywords

B CELL ACTIVATING FACTOR; IN 1; MEMBRANE PROTEIN; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN ASSOCIATED INHIBITOR; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NEP 1 40; NOGO A ANTIBODY; PEPTIDE DERIVATIVE; PROTEIN NOGO; PROTEIN NOGO A; PROTEOCHONDROITIN SULFATE; UNCLASSIFIED DRUG;

DRUG EFFECT; DRUG TARGETING; HUMAN; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NERVE SPROUTING; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SPINAL CORD INJURY; SPINAL CORD REGENERATION;

ANIMALS; AXONS; GPI-LINKED PROTEINS; MICE; MYELIN PROTEINS; MYELIN-ASSOCIATED GLYCOPROTEIN; NERVE REGENERATION; SPINAL CORD INJURIES;

EID: 84859912753     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.05.001     Document Type: Review

References (121)

1. Atwal J.K., Pinkston-Gosse J., Syken J., Stawicki S., Wu Y., Shatz C., Tessier-Lavigne M. PirB is a functional receptor for myelin inhibitors of axonal regeneration. Science 2008, 322:967-970.
2. Bareyre F.M., Kerschensteiner M., Misgeld T., Sanes J.R. Transgenic labeling of the corticospinal tract for monitoring axonal responses to spinal cord injury. Nat. Med. 2005, 11:1355-1360.
3. Bartsch U., Bandtlow C.E., Schnell L., Bartsch S., Spillmann A.A., Rubin B.P., Hillenbrand R., Montag D., Schwab M.E., Schachner M. Lack of evidence that myelin-associated glycoprotein is a major inhibitor of axonal regeneration in the CNS. Neuron 1995, 15:1375-1381.
4. Benson M.D., Romero M.I., Lush M.E., Lu Q.R., Henkemeyer M., Parada L.F. Ephrin-B3 is a myelin-based inhibitor of neurite outgrowth. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:10694-10699.
5. Berry M. Post-injury myelin-breakdown products inhibit axonal growth: an hypothesis to explain the failure of axonal regeneration in the mammalian central nervous system. Bibl. Anat. 1982, 1-11.
6. Blochlinger S., Weinmann O., Schwab M.E., Thallmair M. Neuronal plasticity and formation of new synaptic contacts follow pyramidal lesions and neutralization of Nogo-A: a light and electron microscopic study in the pontine nuclei of adult rats. J. Comp. Neurol. 2001, 433:426-436.
7. Bradbury E.J., McMahon S.B. Spinal cord repair strategies: why do they work?. Nat. Rev. Neurosci. 2006, 7:644-653.
8. Bradbury E.J., Moon L.D., Popat R.J., King V.R., Bennett G.S., Patel P.N., Fawcett J.W., McMahon S.B. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002, 416:636-640.
9. Bregman B.S., Kunkel-Bagden E., Schnell L., Dai H.N., Gao D., Schwab M.E. Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature 1995, 378:498-501.
10. Buchli A.D., Schwab M.E. Inhibition of Nogo: a key strategy to increase regeneration, plasticity and functional recovery of the lesioned central nervous system. Ann. Med. 2005, 37:556-567.
11. Buss A., Schwab M.E. Sequential loss of myelin proteins during Wallerian degeneration in the rat spinal cord. Glia 2003, 42:424-432.
12. Cafferty W.B., Duffy P., Huebner E., Strittmatter S.M. MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma. J. Neurosci. 2010, 30:6825-6837.
13. Cafferty W.B., McGee A.W., Strittmatter S.M. Axonal growth therapeutics: regeneration or sprouting or plasticity?. Trends Neurosci. 2008, 31:215-220.
14. Cafferty W.B., Strittmatter S.M. The Nogo-Nogo receptor pathway limits a spectrum of adult CNS axonal growth. J. Neurosci. 2006, 26:12242-12250.
15. Cao Y., Shumsky J.S., Sabol M.A., Kushner R.A., Strittmatter S., Hamers F.P., Lee D.H., Rabacchi S.A., Murray M. Nogo-66 receptor antagonist peptide (NEP1-40) administration promotes functional recovery and axonal growth after lateral funiculus injury in the adult rat. Neurorehabil. Neural Repair 2008, 22:262-278.
16. Caroni P., Schwab M.E. Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron 1988, 1:85-96.
17. Caroni P., Schwab M.E. Two membrane protein fractions from rat central myelin with inhibitory properties for neurite growth and fibroblast spreading. J. Cell Biol. 1988, 106:1281-1288.
18. Chang K.J., Susuki K., Dours-Zimmermann M.T., Zimmermann D.R., Rasband M.N. Oligodendrocyte myelin glycoprotein does not influence node of ranvier structure or assembly. J. Neurosci. 2010, 30:14476-14481.
19. Chen M.S., Huber A.B., van der Haar M.E., Frank M., Schnell L., Spillmann A.A., Christ F., Schwab M.E. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 2000, 403:434-439.
20. Darian-Smith C. Synaptic plasticity, neurogenesis, and functional recovery after spinal cord injury. Neuroscientist 2009, 15:149-165.
21. Davalos D., Lee J.K., Smith W.B., Brinkman B., Ellisman M.H., Zheng B., Akassoglou K. Stable in vivo imaging of densely populated glia, axons and blood vessels in the mouse spinal cord using two-photon microscopy. J. Neurosci. Methods 2008, 169:1-7.
22. Delekate A., Zagrebelsky M., Kramer S., Schwab M.E., Korte M. NogoA restricts synaptic plasticity in the adult hippocampus on a fast time scale. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:2569-2574.
23. Dimou L., Schnell L., Montani L., Duncan C., Simonen M., Schneider R., Liebscher T., Gullo M., Schwab M.E. Nogo-A-deficient mice reveal strain-dependent differences in axonal regeneration. J. Neurosci. 2006, 26:5591-5603.
24. Domeniconi M., Cao Z., Spencer T., Sivasankaran R., Wang K., Nikulina E., Kimura N., Cai H., Deng K., Gao Y., He Z., Filbin M. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron 2002, 35:283-290.
25. Domeniconi M., Filbin M.T. Overcoming inhibitors in myelin to promote axonal regeneration. J. Neurol. Sci. 2005, 233:43-47.
26. Dray C., Rougon G., Debarbieux F. Quantitative analysis by in vivo imaging of the dynamics of vascular and axonal networks in injured mouse spinal cord. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:9459-9464.
27. Filbin M.T. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat. Rev. Neurosci. 2003, 4:703-713.
28. Fischer D., He Z., Benowitz L.I. Counteracting the Nogo receptor enhances optic nerve regeneration if retinal ganglion cells are in an active growth state. J. Neurosci. 2004, 24:1646-1651.
29. Fouad K., Dietz V., Schwab M.E. Improving axonal growth and functional recovery after experimental spinal cord injury by neutralizing myelin associated inhibitors. Brain Res. Brain Res. Rev. 2001, 36:204-212.
30. Fouad K., Klusman I., Schwab M.E. Regenerating corticospinal fibers in the Marmoset (Callitrix jacchus) after spinal cord lesion and treatment with the anti-Nogo-A antibody IN-1. Eur. J. Neurosci. 2004, 20:2479-2482.
31. Fournier A.E., GrandPre T., Strittmatter S.M. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 2001, 409:341-346.
32. Freund P., Schmidlin E., Wannier T., Bloch J., Mir A., Schwab M.E., Rouiller E.M. Nogo-A-specific antibody treatment enhances sprouting and functional recovery after cervical lesion in adult primates. Nat. Med. 2006, 12:790-792.
33. Freund P., Wannier T., Schmidlin E., Bloch J., Mir A., Schwab M.E., Rouiller E.M. Anti-Nogo-A antibody treatment enhances sprouting of corticospinal axons rostral to a unilateral cervical spinal cord lesion in adult macaque monkey. J. Comp. Neurol. 2007, 502:644-659.
34. Gil V., Bichler Z., Lee J.K., Seira O., Llorens F., Bribian A., Morales R., Claverol-Tinture E., Soriano E., Sumoy L., Zheng B., Del Rio J.A. Developmental expression of the oligodendrocyte myelin glycoprotein in the mouse telencephalon. Cereb. Cortex 2010, 20:1769-1779.
35. Goh E.L., Young J.K., Kuwako K., Tessier-Lavigne M., He Z., Griffin J.W., Ming G.L. beta1-integrin mediates myelin-associated glycoprotein signaling in neuronal growth cones. Mol. Brain 2008, 1:10.
36. Goldberg J.L., Klassen M.P., Hua Y., Barres B.A. Amacrine-signaled loss of intrinsic axon growth ability by retinal ganglion cells. Science 2002, 296:1860-1864.
37. GrandPre T., Li S., Strittmatter S.M. Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 2002, 417:547-551.
38. GrandPre T., Nakamura F., Vartanian T., Strittmatter S.M. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 2000, 403:439-444.
39. Habib A.A., Marton L.S., Allwardt B., Gulcher J.R., Mikol D.D., Hognason T., Chattopadhyay N., Stefansson K. Expression of the oligodendrocyte-myelin glycoprotein by neurons in the mouse central nervous system. J. Neurochem. 1998, 70:1704-1711.
40. Hasegawa Y., Fujitani M., Hata K., Tohyama M., Yamagishi S., Yamashita T. Promotion of axon regeneration by myelin-associated glycoprotein and Nogo through divergent signals downstream of Gi/G. J. Neurosci. 2004, 24:6826-6832.
41. Hauben E., Ibarra A., Mizrahi T., Barouch R., Agranov E., Schwartz M. Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigens. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:15173-15178.
42. Hu F., Strittmatter S.M. The N-terminal domain of Nogo-A inhibits cell adhesion and axonal outgrowth by an integrin-specific mechanism. J. Neurosci. 2008, 28:1262-1269.
43. Huang D.W., McKerracher L., Braun P.E., David S. A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord. Neuron 1999, 24:639-647.
44. Huang J.K., Phillips G.R., Roth A.D., Pedraza L., Shan W., Belkaid W., Mi S., Fex-Svenningsen A., Florens L., Yates J.R., Colman D.R. Glial membranes at the node of Ranvier prevent neurite outgrowth. Science 2005, 310:1813-1817.
45. Hunt D., Coffin R.S., Prinjha R.K., Campbell G., Anderson P.N. Nogo-A expression in the intact and injured nervous system. Mol. Cell. Neurosci. 2003, 24:1083-1102.
46. Ji B., Case L.C., Liu K., Shao Z., Lee X., Yang Z., Wang J., Tian T., Shulga-Morskaya S., Scott M., He Z., Relton J.K., Mi S. Assessment of functional recovery and axonal sprouting in oligodendrocyte-myelin glycoprotein (OMgp) null mice after spinal cord injury. Mol. Cell. Neurosci. 2008, 39:258-267.
47. Ji B., Li M., Budel S., Pepinsky R.B., Walus L., Engber T.M., Strittmatter S.M., Relton J.K. Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury. Eur. J. Neurosci. 2005, 22:587-594.
48. Ji B., Li M., Wu W.T., Yick L.W., Lee X., Shao Z., Wang J., So K.F., McCoy J.M., Pepinsky R.B., Mi S., Relton J.K. LINGO-1 antagonist promotes functional recovery and axonal sprouting after spinal cord injury. Mol. Cell. Neurosci. 2006, 33:311-320.
49. Jorntell H., Hansel C. Synaptic memories upside down: bidirectional plasticity at cerebellar parallel fiber-Purkinje cell synapses. Neuron 2006, 52:227-238.
50. Kerschensteiner M., Schwab M.E., Lichtman J.W., Misgeld T. In vivo imaging of axonal degeneration and regeneration in the injured spinal cord. Nat. Med. 2005, 11:572-577.
51. Kim J.E., Li S., GrandPre T., Qiu D., Strittmatter S.M. Axon regeneration in young adult mice lacking Nogo-A/B. Neuron 2003, 38:187-199.
52. Kim J.E., Liu B.P., Park J.H., Strittmatter S.M. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury. Neuron 2004, 44:439-451.
53. Kokotilo K.J., Eng J.J., Curt A. Reorganization and preservation of motor control of the brain in spinal cord injury: a systematic review. J. Neurotrauma 2009, 26:2113-2126.
54. Kottis V., Thibault P., Mikol D., Xiao Z.C., Zhang R., Dergham P., Braun P.E. Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J. Neurochem. 2002, 82:1566-1569.
55. Lane M.A., Lee K.Z., Fuller D.D., Reier P.J. Spinal circuitry and respiratory recovery following spinal cord injury. Respir. Physiol. Neurobiol. 2009, 169:123-132.
56. Lee H., Raiker S.J., Venkatesh K., Geary R., Robak L.A., Zhang Y., Yeh H.H., Shrager P., Giger R.J. Synaptic function for the Nogo-66 receptor NgR1: regulation of dendritic spine morphology and activity-dependent synaptic strength. J. Neurosci. 2008, 28:2753-2765.
57. Lee J.K., Case L.C., Chan A.F., Zhu Y., Tessier-Lavigne M., Zheng B. Generation of an OMgp allelic series in mice. Genesis 2009, 47:751-756.
58. Lee J.K., Chan A.F., Luu S.M., Zhu Y., Ho C., Tessier-Lavigne M., Zheng B. Reassessment of corticospinal tract regeneration in Nogo-deficient mice. J. Neurosci. 2009, 29:8649-8654.
59. Lee J.K., Chow R., Xie F., Chow S.Y., Tolentino K.E., Zheng B. Combined genetic attenuation of myelin and semaphorin-mediated growth inhibition is insufficient to promote serotonergic axon regeneration. J. Neurosci. 2010, 30:10899-10904.
60. Lee J.K., Geoffroy C.G., Chan A.F., Tolentino K.E., Crawford M.J., Leal M.A., Kang B., Zheng B. Assessing spinal axon regeneration and sprouting in Nogo-, MAG-, and OMgp-deficient mice. Neuron 2010, 66:663-670.
61. Li C., Tropak M.B., Gerlai R., Clapoff S., Abramow-Newerly W., Trapp B., Peterson A., Roder J. Myelination in the absence of myelin-associated glycoprotein. Nature 1994, 369:747-750.
62. Li S., Kim J.E., Budel S., Hampton T.G., Strittmatter S.M. Transgenic inhibition of Nogo-66 receptor function allows axonal sprouting and improved locomotion after spinal injury. Mol. Cell. Neurosci. 2005, 29:26-39.
63. Li S., Liu B.P., Budel S., Li M., Ji B., Walus L., Li W., Jirik A., Rabacchi S., Choi E., Worley D., Sah D.W., Pepinsky B., Lee D., Relton J., Strittmatter S.M. Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury. J. Neurosci. 2004, 24:10511-10520.
64. Li S., Strittmatter S.M. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury. J. Neurosci. 2003, 23:4219-4227.
65. Liebscher T., Schnell L., Schnell D., Scholl J., Schneider R., Gullo M., Fouad K., Mir A., Rausch M., Kindler D., Hamers F.P., Schwab M.E. Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats. Ann. Neurol. 2005, 58:706-719.
66. Liu B.P., Fournier A., GrandPre T., Strittmatter S.M. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science 2002, 297:1190-1193.
67. Liu K., Lu Y., Lee J.K., Samara R., Willenberg R., Sears-Kraxberger I., Tedeschi A., Park K.K., Jin D., Cai B., Xu B., Connolly L., Steward O., Zheng B., He Z. PTEN deletion enhances the regenerative ability of adult corticospinal neurons. Nat. Neurosci. 2010, 13:1075-1081.
68. Lopez P.H., Ahmad A.S., Mehta N.R., Toner M., Rowland E.A., Zhang J., Dore S., Schnaar R.L. Myelin-associated glycoprotein protects neurons from excitotoxicity. J. Neurochem. 2011, 116:900-908.
69. Low K., Culbertson M., Bradke F., Tessier-Lavigne M., Tuszynski M.H. Netrin-1 is a novel myelin-associated inhibitor to axon growth. J. Neurosci. 2008, 28:1099-1108.
70. MacDermid V.E., McPhail L.T., Tsang B., Rosenthal A., Davies A., Ramer M.S. A soluble Nogo receptor differentially affects plasticity of spinally projecting axons. Eur. J. Neurosci. 2004, 20:2567-2579.
71. Maier I.C., Ichiyama R.M., Courtine G., Schnell L., Lavrov I., Edgerton V.R., Schwab M.E. Differential effects of anti-Nogo-A antibody treatment and treadmill training in rats with incomplete spinal cord injury. Brain 2009, 132:1426-1440.
72. McGee A.W., Yang Y., Fischer Q.S., Daw N.W., Strittmatter S.M. Experience-driven plasticity of visual cortex limited by myelin and Nogo receptor. Science 2005, 309:2222-2226.
73. McKerracher L., David S., Jackson D.L., Kottis V., Dunn R.J., Braun P.E. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron 1994, 13:805-811.
74. Mehta N.R., Nguyen T., Bullen J.W., Griffin J.W., Schnaar R.L. Myelin-associated glycoprotein (MAG) protects neurons from acute toxicity using a ganglioside-dependent mechanism. ACS Chem. Neurosci. 2010, 1:215-222.
75. Mikol D.D., Stefansson K. A phosphatidylinositol-linked peanut agglutinin-binding glycoprotein in central nervous system myelin and on oligodendrocytes. J. Cell Biol. 1988, 106:1273-1279.
76. Moreau-Fauvarque C., Kumanogoh A., Camand E., Jaillard C., Barbin G., Boquet I., Love C., Jones E.Y., Kikutani H., Lubetzki C., Dusart I., Chedotal A. The transmembrane semaphorin Sema4D/CD100, an inhibitor of axonal growth, is expressed on oligodendrocytes and upregulated after CNS lesion. J. Neurosci. 2003, 23:9229-9239.
77. Mountney A., Zahner M.R., Lorenzini I., Oudega M., Schramm L.P., Schnaar R.L. Sialidase enhances recovery from spinal cord contusion injury. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:11561-11566.
78. Mukhopadhyay G., Doherty P., Walsh F.S., Crocker P.R., Filbin M.T. A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron 1994, 13:757-767.
79. Mullner A., Gonzenbach R.R., Weinmann O., Schnell L., Liebscher T., Schwab M.E. Lamina-specific restoration of serotonergic projections after Nogo-A antibody treatment of spinal cord injury in rats. Eur. J. Neurosci. 2008, 27:326-333.
80. Nakamura Y., Fujita Y., Ueno M., Takai T., Yamashita T. Paired immunoglobulin-like receptor B knockout does not enhance axonal regeneration or locomotor recovery after spinal cord injury. J. Biol. Chem. 2011, 286:1876-1883.
81. Nguyen T., Mehta N.R., Conant K., Kim K.J., Jones M., Calabresi P.A., Melli G., Hoke A., Schnaar R.L., Ming G.L., Song H., Keswani S.C., Griffin J.W. Axonal protective effects of the myelin-associated glycoprotein. J. Neurosci. 2009, 29:630-637.
82. Ondarza A.B., Ye Z., Hulsebosch C.E. Direct evidence of primary afferent sprouting in distant segments following spinal cord injury in the rat: colocalization of GAP-43 and CGRP. Exp. Neurol. 2003, 184:373-380.
83. Park J.B., Yiu G., Kaneko S., Wang J., Chang J., He X.L., Garcia K.C., He Z. A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors. Neuron 2005, 45:345-351.
84. Park K.K., Liu K., Hu Y., Smith P.D., Wang C., Cai B., Xu B., Connolly L., Kramvis I., Sahin M., He Z. Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 2008, 322:963-966.
85. Pizzorusso T., Medini P., Berardi N., Chierzi S., Fawcett J.W., Maffei L. Reactivation of ocular dominance plasticity in the adult visual cortex. Science 2002, 298:1248-1251.
86. Prinjha R., Moore S.E., Vinson M., Blake S., Morrow R., Christie G., Michalovich D., Simmons D.L., Walsh F.S. Inhibitor of neurite outgrowth in humans. Nature 2000, 403:383-384.
87. Quarles R.H. Myelin sheaths: glycoproteins involved in their formation, maintenance and degeneration. Cell. Mol. Life Sci. 2002, 59:1851-1871.
88. Quarles R.H. Myelin-associated glycoprotein (MAG): past, present and beyond. J. Neurochem. 2007, 100:1431-1448.
89. Raiker S.J., Lee H., Baldwin K.T., Duan Y., Shrager P., Giger R.J. Oligodendrocyte-myelin glycoprotein and Nogo negatively regulate activity-dependent synaptic plasticity. J. Neurosci. 2010, 30:12432-12445.
90. Saruhashi Y., Young W., Perkins R. The recovery of 5-HT immunoreactivity in lumbosacral spinal cord and locomotor function after thoracic hemisection. Exp. Neurol. 1996, 139:203-213.
91. Savio T., Schwab M.E. Rat CNS white matter, but not gray matter, is nonpermissive for neuronal cell adhesion and fiber outgrowth. J. Neurosci. 1989, 9:1126-1133.
92. Schnaar R.L. Brain gangliosides in axon-myelin stability and axon regeneration. FEBS Lett. 2010, 584:1741-1747.
93. Schnell L., Schwab M.E. Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature 1990, 343:269-272.
94. Schnell L., Schwab M.E. Sprouting and regeneration of lesioned corticospinal tract fibres in the adult rat spinal cord. Eur. J. Neurosci. 1993, 5:1156-1171.
95. Shao Z., Browning J.L., Lee X., Scott M.L., Shulga-Morskaya S., Allaire N., Thill G., Levesque M., Sah D., McCoy J.M., Murray B., Jung V., Pepinsky R.B., Mi S. TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration. Neuron 2005, 45:353-359.
96. Shen Y., Tenney A.P., Busch S.A., Horn K.P., Cuascut F.X., Liu K., He Z., Silver J., Flanagan J.G. PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Science 2009, 326:592-596.
97. Sicotte M., Tsatas O., Jeong S.Y., Cai C.Q., He Z., David S. Immunization with myelin or recombinant Nogo-66/MAG in alum promotes axon regeneration and sprouting after corticospinal tract lesions in the spinal cord. Mol. Cell. Neurosci. 2003, 23:251-263.
98. Simonen M., Pedersen V., Weinmann O., Schnell L., Buss A., Ledermann B., Christ F., Sansig G., van der Putten H., Schwab M.E. Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron 2003, 38:201-211.
99. Song X.Y., Zhong J.H., Wang X., Zhou X.F. Suppression of p75NTR does not promote regeneration of injured spinal cord in mice. J. Neurosci. 2004, 24:542-546.
100. Spillmann A.A., Bandtlow C.E., Lottspeich F., Keller F., Schwab M.E. Identification and characterization of a bovine neurite growth inhibitor (bNI-220). J. Biol. Chem. 1998, 273:19283-19293.
101. Steward O., Sharp K., Yee K.M., Hofstadter M. A re-assessment of the effects of a Nogo-66 receptor antagonist on regenerative growth of axons and locomotor recovery after spinal cord injury in mice. Exp. Neurol. 2008, 209:446-468.
102. Steward O., Zheng B., Banos K., Yee K.M. Response to: Kim et al., "Axon regeneration in young adult mice lacking Nogo-A/B." Neuron 38, 187-199. Neuron 2007, 54:191-195.
103. Steward O., Zheng B., Ho C., Anderson K., Tessier-Lavigne M. The dorsolateral corticospinal tract in mice: an alternative route for corticospinal input to caudal segments following dorsal column lesions. J. Comp. Neurol. 2004, 472:463-477.
104. Steward O., Zheng B., Tessier-Lavigne M. False resurrections: distinguishing regenerated from spared axons in the injured central nervous system. J. Comp. Neurol. 2003, 459:1-8.
105. Syken J., Grandpre T., Kanold P.O., Shatz C.J. PirB restricts ocular-dominance plasticity in visual cortex. Science 2006, 313:1795-1800.
106. Takai T. Paired immunoglobulin-like receptors and their MHC class I recognition. Immunology 2005, 115:433-440.
107. Thallmair M., Metz G.A., Z'Graggen W.J., Raineteau O., Kartje G.L., Schwab M.E. Neurite growth inhibitors restrict plasticity and functional recovery following corticospinal tract lesions. Nat. Neurosci. 1998, 1:124-131.
108. Venkatesh K., Chivatakarn O., Lee H., Joshi P.S., Kantor D.B., Newman B.A., Mage R., Rader C., Giger R.J. The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein. J. Neurosci. 2005, 25:808-822.
109. Viskochil D., Cawthon R., O'Connell P., Xu G.F., Stevens J., Culver M., Carey J., White R. The gene encoding the oligodendrocyte-myelin glycoprotein is embedded within the neurofibromatosis type 1 gene. Mol. Cell. Biol. 1991, 11:906-912.
110. Voeltz G.K., Prinz W.A., Shibata Y., Rist J.M., Rapoport T.A. A class of membrane proteins shaping the tubular endoplasmic reticulum. Cell 2006, 124:573-586.
111. Vourc'h P., Andres C. Oligodendrocyte myelin glycoprotein (OMgp): evolution, structure and function. Brain Res. Brain Res. Rev. 2004, 45:115-124.
112. Wang K.C., Kim J.A., Sivasankaran R., Segal R., He Z. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 2002, 420:74-78.
113. Wang K.C., Koprivica V., Kim J.A., Sivasankaran R., Guo Y., Neve R.L., He Z. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 2002, 417:941-944.
114. Wang X., Baughman K.W., Basso D.M., Strittmatter S.M. Delayed Nogo receptor therapy improves recovery from spinal cord contusion. Ann. Neurol. 2006, 60:540-549.
115. Wang X., Chun S.J., Treloar H., Vartanian T., Greer C.A., Strittmatter S.M. Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J. Neurosci. 2002, 22:5505-5515.
116. Wong S.T., Henley J.R., Kanning K.C., Huang K.H., Bothwell M., Poo M.M. A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat. Neurosci. 2002, 5:1302-1308.
117. Z'Graggen W.J., Metz G.A., Kartje G.L., Thallmair M., Schwab M.E. Functional recovery and enhanced corticofugal plasticity after unilateral pyramidal tract lesion and blockade of myelin-associated neurite growth inhibitors in adult rats. J. Neurosci. 1998, 18:4744-4757.
118. Zhang L., Zheng S., Wu H., Wu Y., Liu S., Fan M., Zhang J. Identification of BLyS (B lymphocyte stimulator), a non-myelin-associated protein, as a functional ligand for Nogo-66 receptor. J. Neurosci. 2009, 29:6348-6352.
119. Zheng B., Atwal J., Ho C., Case L., He X.L., Garcia K.C., Steward O., Tessier-Lavigne M. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:1205-1210.
120. Zheng B., Ho C., Li S., Keirstead H., Steward O., Tessier-Lavigne M. Lack of enhanced spinal regeneration in Nogo-deficient mice. Neuron 2003, 38:213-224.
121. Zheng B., Lee J.K., Xie F. Genetic mouse models for studying inhibitors of spinal axon regeneration. Trends Neurosci. 2006, 29:640-646.